McKinley Capital Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-8,308
Closed -$425K 197
2019
Q3
$425K Sell
8,308
-350
-4% -$16.7K 0.03% 150
2019
Q2
$366K Sell
8,658
-1,871
-18% -$81.2K 0.02% 195
2019
Q1
$520K Sell
10,529
-809
-7% -$36.6K 0.04% 156
2018
Q4
$491K Buy
11,338
+2,745
+32% +$137K 0.04% 156
2018
Q3
$488K Buy
8,593
+1,835
+27% +$96.6K 0.03% 158
2018
Q2
$341K Buy
6,758
+1,838
+37% +$95.8K 0.02% 177
2018
Q1
$245K Buy
+4,920
New +$231K 0.01% 208
2017
Q3
Sell
-340
Closed -$11K 394
2017
Q2
$11K Buy
+340
New +$10.7K ﹤0.01% 436
2016
Q3
Sell
-311,460
Closed -$7.42M 542
2016
Q2
$7.42M Sell
311,460
-85
-0% -$2.04K 0.36% 88
2016
Q1
$7.4M Sell
311,545
-247
-0.1% -$6.04K 0.36% 75
2015
Q4
$8.67M Sell
311,792
-40,111
-11% -$1.01M 0.4% 56
2015
Q3
$7.27M Buy
351,903
+190,181
+118% +$4.82M 0.35% 71
2015
Q2
$4.15M Buy
+161,722
New +$4.1M 0.18% 151
2014
Q3
Sell
-218,884
Closed -$5.24M 340
2014
Q2
$5.24M Buy
+218,884
New +$5.28M 0.21% 120

Other funds holding GMED

McKinley Capital Management's GMED Position: Q4 2019 in Review

McKinley Capital Management sold out of Globus Medical (GMED) in Q4 2019, closing a stake of 8,308 shares — an estimated $425K sold.

McKinley Capital Management first reported a position in GMED in Q2 2014 and held it in 14 quarters. The position peaked at $8.67M in Q4 2015. 307 funds tracked by Wall St. Rank hold GMED as of Q4 2019.

  • McKinley Capital Management reported no remaining Globus Medical position as of Q4 2019 after selling out during the quarter.
  • McKinley Capital Management sold 8,308 Globus Medical shares in Q4 2019, an estimated $425K.
  • McKinley Capital Management first reported a position in Globus Medical in Q2 2014 and held it in 14 quarters.
  • McKinley Capital Management's Globus Medical position peaked at $8.67M in Q4 2015.
  • 307 funds tracked by Wall St. Rank held Globus Medical as of Q4 2019.

Based on McKinley Capital Management's 13F filing for Q4 2019, filed 23 Jan 2020.